Skip to content

Universe Pharmaceuticals INC

UPC

CIK 0001809616

← back to feed
Revenue (TTM)
$17.86B
−22.4% YoY FY Sep 2025
Net Income (TTM)
−$3.67B
+57.9% YoY FY Sep 2025
EPS Diluted (TTM)
−$8.06
+98.7% YoY FY Sep 2025
Gross Margin
35.3%
FY Sep 2025
Operating Margin
-16.3%
FY Sep 2025
Net Margin
-20.6%
FY Sep 2025
Free Cash Flow (TTM)
−$5.32B
FY Sep 2025
Cash
$14.24M
FY Sep 2025
Total Debt
$7.15B
FY Sep 2025
Shares Outstanding
563.34K sh
FY Sep 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings